Eli Lilly expands Zepbound access with flat-rate pricing and new vial options, supporting wider obesity treatment access without insurance barriers.
Eli Lilly Launches Flat Pricing For Zepbound, Capping Monthly Cost At $499
Where Today's News Shapes Tomorrow